Regional homogeneity alterations reflect pain and emotional dysregulation in adenomyosis
article
OA: gold
CC0
Abstract
PURPOSE: Adenomyosis (AM) with dysmenorrhea (AMD) is a global public health concern that may involve abnormal brain function and heightened vulnerability to anxiety and depression. This study aimed to investigate static and dynamic regional homogeneity (sReHo and dReHo) alterations in AMD and their associations with clinical symptoms. METHODS: ) were calculated for significant clusters. Partial correlation analyses assessed relationships between regional homogeneity (ReHo) alterations and clinical measures, controlling for medication use, menstrual phase and psychiatric history. RESULTS: < 0.001). CONCLUSIONS: AMD is characterized by altered intrinsic brain activity in pain- and emotion-related regions, supporting a central mechanism underlying chronic pain and affective symptoms. These findings provide neuroimaging evidence for AMD-related brain dysfunction. Longitudinal studies with larger cohorts and hormonal control are warranted to confirm these results and clarify causal relationships.
My notes (saved in your browser only)
Outcome instruments
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (58)
- Adenomyosis incidence, prevalence and treatment: United States population-based study 2006–2015 via openalex
- Cytokines, Angiogenesis, and Extracellular Matrix Degradation are Augmented by Oxidative Stress in Endometriosis via openalex
- Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms via openalex
- Epidemiology of Adenomyosis via openalex
- Expression of Inflammatory and Neurogenic Mediators in Adenomyosis: A Pathogenetic Role via openalex
- Guideline No. 437: Diagnosis and Management of Adenomyosis via openalex
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? via openalex
- Pathogenesis of Endometriosis: The Origin of Pain and Subfertility via openalex
- Prevalence of adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding, pelvic pain or uterine prolapse – A retrospective cohort study via openalex
- Serum <scp>CA125</scp> as a biomarker for dysmenorrhea in adenomyosis via openalex
- The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis via openalex
- Urocortin and corticotrophin-releasing hormone receptor type 2 mRNA are highly expressed in deep infiltrating endometriotic lesions via openalex
- W2168733416 via openalex
- W2337323496 via openalex
- W2567444348 via openalex
- W2604834320 via openalex
- W2765882215 via openalex
- W2890965113 via openalex
- W2894496056 via openalex
- W2939952560 via openalex
- W2942522245 via openalex
- W2989384704 via openalex
- W3019746794 via openalex
- W3109145642 via openalex
- W3109346479 via openalex
- W3111655469 via openalex
- W3111831987 via openalex
- W3116315554 via openalex
- W3123707718 via openalex
- W3125325448 via openalex
- W3207259471 via openalex
- W3213133758 via openalex
- W4200446887 via openalex
- W4205193574 via openalex
- W4292299683 via openalex
- W4293109573 via openalex
- W4294543062 via openalex
- W4295213413 via openalex
- W4302761382 via openalex
- W4310940024 via openalex
- W4311033765 via openalex
- W4322775402 via openalex
- W4378377205 via openalex
- W4388020615 via openalex
- W4388485350 via openalex
- W1582241009 via openalex
- W4391692462 via openalex
- W1945842400 via openalex
- W1989522832 via openalex
- W1992485217 via openalex
- W1996757687 via openalex
- W2007213925 via openalex
- W2025704738 via openalex
- W2034645316 via openalex
- W2048984802 via openalex
- W2087932219 via openalex
- W2120256657 via openalex
- W2145674835 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pmc
- last seen: 2026-05-13T20:22:03.195721+00:00
- pubmed
- last seen: 2026-05-21T00:30:26.686341+00:00
License: CC0
· commercial use OK